 | • レポートコード：D0804-16878 • 出版社/出版日：GlobalInfoResearch / 2020年8月3日 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、126ページ • 納品方法：Eメール • 産業分類：医療 |
| Single User | ￥487,200 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥730,800 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥974,400 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートでは、ウイルスベクター・プラスミドDNA製造の世界市場を広く調査・分析し、今後の市場展望をまとめております。ウイルスベクター・プラスミドDNA製造の種類別市場規模（プラスミドDNA、ウイルスベクター）、用途別市場規模（がん、遺伝性疾患、ウイルス感染症、その他）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェアなどの情報を掲載しています。 ・市場概要 ・企業情報（販売量、市場シェア、製品概要、SWOT分析）：BioReliance、Richter-Helm、UniQure、Cobra Biologics、MassBiologics、Oxford BioMedica、Lonza、MolMed、FinVector、FUJIFILM Diosynth Biotechnologies、Brammer Bio、Aldevron、VGXI、Biovian、Eurogentec、PlasmidFactory、Cell and Gene Therapy Catapult ・地域別グローバル市場分析 2015年-2020年 ・ウイルスベクター・プラスミドDNA製造の北米市場（アメリカ、カナダ、メキシコ） ・ウイルスベクター・プラスミドDNA製造のヨーロッパ市場（ドイツ、イギリス、フランス、ロシア、イタリア） ・ウイルスベクター・プラスミドDNA製造のアジア市場（中国、日本、韓国、インド、東南アジア、オーストラリア） ・ウイルスベクター・プラスミドDNA製造の南米市場（ブラジル、アルゼンチン） ・ウイルスベクター・プラスミドDNA製造の中東・アフリカ市場（サウジアラビア、トルコ、エジプト、南アフリカ） ・種類別分析：プラスミドDNA、ウイルスベクター ・用途別分析：がん、遺伝性疾患、ウイルス感染症、その他 ・地域別市場規模予測 2021年-2025年 ・調査の結果・結論 |
Market Overview
The Viral Vectors and Plasmid DNA Manufacturing market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
The most likely (base case) scenario is that the global Viral Vectors and Plasmid DNA Manufacturing sales will be xx in 2020 from Viral Vectors and Plasmid DNA Manufacturing million in 2019, with a change xx% between 2019 and 2020. In addition, based on the latest study, it is to predict that the Covid-19 will be under control in key countries like the United States, Western Europe, East Asia, by the end of Q2 (June), and will resume normal production in Q3 and Q4, the global Viral Vectors and Plasmid DNA Manufacturing market size is expected to grow at xx% or more annually for the next five years.
This report also researches and evaluates the impact of Covid-19 outbreak on the Viral Vectors and Plasmid DNA Manufacturing industry, involving potential opportunity and challenges, drivers and risks. We present the impact assessment of Covid-19 effects on Viral Vectors and Plasmid DNA Manufacturing and market growth forecast based on different scenario (optimistic, pessimistic, very optimistic, most likely etc.).
Market segmentation
Viral Vectors and Plasmid DNA Manufacturing market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Viral Vectors and Plasmid DNA Manufacturing market has been segmented into:
Plasmid DNA
Viral Vectors
By Application, Viral Vectors and Plasmid DNA Manufacturing has been segmented into:
Cancers
Inherited Disorders
Viral Infections
Others
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Viral Vectors and Plasmid DNA Manufacturing market presented in the report. This section sheds light on the sales growth of different regional and country-level Viral Vectors and Plasmid DNA Manufacturing markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Viral Vectors and Plasmid DNA Manufacturing market.
The report offers in-depth assessment of the growth and other aspects of the Viral Vectors and Plasmid DNA Manufacturing market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Australia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Competitive Landscape and Viral Vectors and Plasmid DNA Manufacturing Market Share Analysis
Viral Vectors and Plasmid DNA Manufacturing competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Viral Vectors and Plasmid DNA Manufacturing sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Viral Vectors and Plasmid DNA Manufacturing sales, revenue and market share for each player covered in this report.
The major players covered in Viral Vectors and Plasmid DNA Manufacturing are:
BioReliance
Richter-Helm
UniQure
Cobra Biologics
MassBiologics
Oxford BioMedica
Lonza
MolMed
FinVector
FUJIFILM Diosynth Biotechnologies
Brammer Bio
Aldevron
VGXI
Biovian
Eurogentec
PlasmidFactory
Cell and Gene Therapy Catapult
1 Viral Vectors and Plasmid DNA Manufacturing Market Overview
1.1 Product Overview and Scope of Viral Vectors and Plasmid DNA Manufacturing
1.2 Classification of Viral Vectors and Plasmid DNA Manufacturing by Type
1.2.1 Global Viral Vectors and Plasmid DNA Manufacturing Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Global Viral Vectors and Plasmid DNA Manufacturing Revenue Market Share by Type in 2019
1.2.3 Plasmid DNA
1.2.4 Viral Vectors
1.3 Global Viral Vectors and Plasmid DNA Manufacturing Market by Application
1.3.1 Overview: Global Viral Vectors and Plasmid DNA Manufacturing Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Cancers
1.3.3 Inherited Disorders
1.3.4 Viral Infections
1.3.5 Others
1.4 Global Viral Vectors and Plasmid DNA Manufacturing Market by Regions
1.4.1 Global Viral Vectors and Plasmid DNA Manufacturing Market Size by Regions: 2015 VS 2019 VS 2025
1.4.2 Global Market Size of Viral Vectors and Plasmid DNA Manufacturing (2015-2025)
1.4.3 North America (USA, Canada and Mexico) Viral Vectors and Plasmid DNA Manufacturing Status and Prospect (2015-2025)
1.4.4 Europe (Germany, France, UK, Russia and Italy) Viral Vectors and Plasmid DNA Manufacturing Status and Prospect (2015-2025)
1.4.5 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Viral Vectors and Plasmid DNA Manufacturing Status and Prospect (2015-2025)
1.4.6 South America (Brazil, Argentina, Colombia) Viral Vectors and Plasmid DNA Manufacturing Status and Prospect (2015-2025)
1.4.7 Middle East & Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Viral Vectors and Plasmid DNA Manufacturing Status and Prospect (2015-2025)
1.5 COVID-19 Outbreak: Viral Vectors and Plasmid DNA Manufacturing Industry Impact
1.5.1 COVID-19 Potential Implications for the Viral Vectors and Plasmid DNA Manufacturing
1.5.1.1 Scenario One: Very Optimistic: COVID-19 has No Influence on Viral Vectors and Plasmid DNA Manufacturing
1.5.1.2 Scenario Two: Optimistic: COVID-19 Will Be Under Control by the End of April
1.5.1.3 Scenario Three: Gloomy: COVID-19 Will Be Under Control Between Q3 and Q4
1.5.1.4 Scenario Four: Most Likely: COVID-19 Will Be Under Control by the End of Q2
1.5.2 Opportunity Analysis in Covid-19 Crisis
1.5.3 Market Risk and Restraints
1.5.4 Market Driving Force
2 Company Profiles
2.1 BioReliance
2.1.1 BioReliance Details
2.1.2 BioReliance Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 BioReliance SWOT Analysis
2.1.4 BioReliance Product and Services
2.1.5 BioReliance Viral Vectors and Plasmid DNA Manufacturing Revenue, Gross Margin and Market Share (2018-2019)
2.2 Richter-Helm
2.2.1 Richter-Helm Details
2.2.2 Richter-Helm Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Richter-Helm SWOT Analysis
2.2.4 Richter-Helm Product and Services
2.2.5 Richter-Helm Viral Vectors and Plasmid DNA Manufacturing Revenue, Gross Margin and Market Share (2018-2019)
2.3 UniQure
2.3.1 UniQure Details
2.3.2 UniQure Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 UniQure SWOT Analysis
2.3.4 UniQure Product and Services
2.3.5 UniQure Viral Vectors and Plasmid DNA Manufacturing Revenue, Gross Margin and Market Share (2018-2019)
2.4 Cobra Biologics
2.4.1 Cobra Biologics Details
2.4.2 Cobra Biologics Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Cobra Biologics SWOT Analysis
2.4.4 Cobra Biologics Product and Services
2.4.5 Cobra Biologics Viral Vectors and Plasmid DNA Manufacturing Revenue, Gross Margin and Market Share (2018-2019)
2.5 MassBiologics
2.5.1 MassBiologics Details
2.5.2 MassBiologics Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 MassBiologics SWOT Analysis
2.5.4 MassBiologics Product and Services
2.5.5 MassBiologics Viral Vectors and Plasmid DNA Manufacturing Revenue, Gross Margin and Market Share (2018-2019)
2.6 Oxford BioMedica
2.6.1 Oxford BioMedica Details
2.6.2 Oxford BioMedica Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 Oxford BioMedica SWOT Analysis
2.6.4 Oxford BioMedica Product and Services
2.6.5 Oxford BioMedica Viral Vectors and Plasmid DNA Manufacturing Revenue, Gross Margin and Market Share (2018-2019)
2.7 Lonza
2.7.1 Lonza Details
2.7.2 Lonza Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 Lonza SWOT Analysis
2.7.4 Lonza Product and Services
2.7.5 Lonza Viral Vectors and Plasmid DNA Manufacturing Revenue, Gross Margin and Market Share (2018-2019)
2.8 MolMed
2.8.1 MolMed Details
2.8.2 MolMed Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 MolMed SWOT Analysis
2.8.4 MolMed Product and Services
2.8.5 MolMed Viral Vectors and Plasmid DNA Manufacturing Revenue, Gross Margin and Market Share (2018-2019)
2.9 FinVector
2.9.1 FinVector Details
2.9.2 FinVector Major Business and Total Revenue (Financial Highlights) Analysis
2.9.3 FinVector SWOT Analysis
2.9.4 FinVector Product and Services
2.9.5 FinVector Viral Vectors and Plasmid DNA Manufacturing Revenue, Gross Margin and Market Share (2018-2019)
2.10 FUJIFILM Diosynth Biotechnologies
2.10.1 FUJIFILM Diosynth Biotechnologies Details
2.10.2 FUJIFILM Diosynth Biotechnologies Major Business and Total Revenue (Financial Highlights) Analysis
2.10.3 FUJIFILM Diosynth Biotechnologies SWOT Analysis
2.10.4 FUJIFILM Diosynth Biotechnologies Product and Services
2.10.5 FUJIFILM Diosynth Biotechnologies Viral Vectors and Plasmid DNA Manufacturing Revenue, Gross Margin and Market Share (2018-2019)
2.11 Brammer Bio
2.11.1 Brammer Bio Details
2.11.2 Brammer Bio Major Business and Total Revenue (Financial Highlights) Analysis
2.11.3 Brammer Bio SWOT Analysis
2.11.4 Brammer Bio Product and Services
2.11.5 Brammer Bio Viral Vectors and Plasmid DNA Manufacturing Revenue, Gross Margin and Market Share (2018-2019)
2.12 Aldevron
2.12.1 Aldevron Details
2.12.2 Aldevron Major Business and Total Revenue (Financial Highlights) Analysis
2.12.3 Aldevron SWOT Analysis
2.12.4 Aldevron Product and Services
2.12.5 Aldevron Viral Vectors and Plasmid DNA Manufacturing Revenue, Gross Margin and Market Share (2018-2019)
2.13 VGXI
2.13.1 VGXI Details
2.13.2 VGXI Major Business and Total Revenue (Financial Highlights) Analysis
2.13.3 VGXI SWOT Analysis
2.13.4 VGXI Product and Services
2.13.5 VGXI Viral Vectors and Plasmid DNA Manufacturing Revenue, Gross Margin and Market Share (2018-2019)
2.14 Biovian
2.14.1 Biovian Details
2.14.2 Biovian Major Business and Total Revenue (Financial Highlights) Analysis
2.14.3 Biovian SWOT Analysis
2.14.4 Biovian Product and Services
2.14.5 Biovian Viral Vectors and Plasmid DNA Manufacturing Revenue, Gross Margin and Market Share (2018-2019)
2.15 Eurogentec
2.15.1 Eurogentec Details
2.15.2 Eurogentec Major Business and Total Revenue (Financial Highlights) Analysis
2.15.3 Eurogentec SWOT Analysis
2.15.4 Eurogentec Product and Services
2.15.5 Eurogentec Viral Vectors and Plasmid DNA Manufacturing Revenue, Gross Margin and Market Share (2018-2019)
2.16 PlasmidFactory
2.16.1 PlasmidFactory Details
2.16.2 PlasmidFactory Major Business and Total Revenue (Financial Highlights) Analysis
2.16.3 PlasmidFactory SWOT Analysis
2.16.4 PlasmidFactory Product and Services
2.16.5 PlasmidFactory Viral Vectors and Plasmid DNA Manufacturing Revenue, Gross Margin and Market Share (2018-2019)
2.17 Cell and Gene Therapy Catapult
2.17.1 Cell and Gene Therapy Catapult Details
2.17.2 Cell and Gene Therapy Catapult Major Business and Total Revenue (Financial Highlights) Analysis
2.17.3 Cell and Gene Therapy Catapult SWOT Analysis
2.17.4 Cell and Gene Therapy Catapult Product and Services
2.17.5 Cell and Gene Therapy Catapult Viral Vectors and Plasmid DNA Manufacturing Revenue, Gross Margin and Market Share (2018-2019)
3 Market Competition, by Players
3.1 Global Viral Vectors and Plasmid DNA Manufacturing Revenue and Share by Players (2015-2020)
3.2 Market Concentration Rate
3.2.1 Top 5 Viral Vectors and Plasmid DNA Manufacturing Players Market Share
3.2.2 Top 10 Viral Vectors and Plasmid DNA Manufacturing Players Market Share
3.3 Market Competition Trend
4 Market Size by Regions
4.1 Global Viral Vectors and Plasmid DNA Manufacturing Revenue and Market Share by Regions
4.2 North America Viral Vectors and Plasmid DNA Manufacturing Revenue and Growth Rate (2015-2020)
4.3 Europe Viral Vectors and Plasmid DNA Manufacturing Revenue and Growth Rate (2015-2020)
4.4 Asia-Pacific Viral Vectors and Plasmid DNA Manufacturing Revenue and Growth Rate (2015-2020)
4.5 South America Viral Vectors and Plasmid DNA Manufacturing Revenue and Growth Rate (2015-2020)
4.6 Middle East & Africa Viral Vectors and Plasmid DNA Manufacturing Revenue and Growth Rate (2015-2020)
5 North America Viral Vectors and Plasmid DNA Manufacturing Revenue by Countries
5.1 North America Viral Vectors and Plasmid DNA Manufacturing Revenue by Countries (2015-2020)
5.2 USA Viral Vectors and Plasmid DNA Manufacturing Revenue and Growth Rate (2015-2020)
5.3 Canada Viral Vectors and Plasmid DNA Manufacturing Revenue and Growth Rate (2015-2020)
5.4 Mexico Viral Vectors and Plasmid DNA Manufacturing Revenue and Growth Rate (2015-2020)
6 Europe Viral Vectors and Plasmid DNA Manufacturing Revenue by Countries
6.1 Europe Viral Vectors and Plasmid DNA Manufacturing Revenue by Countries (2015-2020)
6.2 Germany Viral Vectors and Plasmid DNA Manufacturing Revenue and Growth Rate (2015-2020)
6.3 UK Viral Vectors and Plasmid DNA Manufacturing Revenue and Growth Rate (2015-2020)
6.4 France Viral Vectors and Plasmid DNA Manufacturing Revenue and Growth Rate (2015-2020)
6.5 Russia Viral Vectors and Plasmid DNA Manufacturing Revenue and Growth Rate (2015-2020)
6.6 Italy Viral Vectors and Plasmid DNA Manufacturing Revenue and Growth Rate (2015-2020)
7 Asia-Pacific Viral Vectors and Plasmid DNA Manufacturing Revenue by Countries
7.1 Asia-Pacific Viral Vectors and Plasmid DNA Manufacturing Revenue by Countries (2015-2020)
7.2 China Viral Vectors and Plasmid DNA Manufacturing Revenue and Growth Rate (2015-2020)
7.3 Japan Viral Vectors and Plasmid DNA Manufacturing Revenue and Growth Rate (2015-2020)
7.4 Korea Viral Vectors and Plasmid DNA Manufacturing Revenue and Growth Rate (2015-2020)
7.5 India Viral Vectors and Plasmid DNA Manufacturing Revenue and Growth Rate (2015-2020)
7.6 Southeast Asia Viral Vectors and Plasmid DNA Manufacturing Revenue and Growth Rate (2015-2020)
8 South America Viral Vectors and Plasmid DNA Manufacturing Revenue by Countries
8.1 South America Viral Vectors and Plasmid DNA Manufacturing Revenue by Countries (2015-2020)
8.2 Brazil Viral Vectors and Plasmid DNA Manufacturing Revenue and Growth Rate (2015-2020)
8.3 Argentina Viral Vectors and Plasmid DNA Manufacturing Revenue and Growth Rate (2015-2020)
9 Middle East & Africa Revenue Viral Vectors and Plasmid DNA Manufacturing by Countries
9.1 Middle East & Africa Viral Vectors and Plasmid DNA Manufacturing Revenue by Countries (2015-2020)
9.2 Saudi Arabia Viral Vectors and Plasmid DNA Manufacturing Revenue and Growth Rate (2015-2020)
9.3 UAE Viral Vectors and Plasmid DNA Manufacturing Revenue and Growth Rate (2015-2020)
9.4 Egypt Viral Vectors and Plasmid DNA Manufacturing Revenue and Growth Rate (2015-2020)
9.5 South Africa Viral Vectors and Plasmid DNA Manufacturing Revenue and Growth Rate (2015-2020)
10 Market Size Segment by Type
10.1 Global Viral Vectors and Plasmid DNA Manufacturing Revenue and Market Share by Type (2015-2020)
10.2 Global Viral Vectors and Plasmid DNA Manufacturing Market Forecast by Type (2019-2024)
10.3 Plasmid DNA Revenue Growth Rate (2015-2025)
10.4 Viral Vectors Revenue Growth Rate (2015-2025)
11 Global Viral Vectors and Plasmid DNA Manufacturing Market Segment by Application
11.1 Global Viral Vectors and Plasmid DNA Manufacturing Revenue Market Share by Application (2015-2020)
11.2 Viral Vectors and Plasmid DNA Manufacturing Market Forecast by Application (2019-2024)
11.3 Cancers Revenue Growth (2015-2020)
11.4 Inherited Disorders Revenue Growth (2015-2020)
11.5 Viral Infections Revenue Growth (2015-2020)
11.6 Others Revenue Growth (2015-2020)
12 Global Viral Vectors and Plasmid DNA Manufacturing Market Size Forecast (2021-2025)
12.1 Global Viral Vectors and Plasmid DNA Manufacturing Market Size Forecast (2021-2025)
12.2 Global Viral Vectors and Plasmid DNA Manufacturing Market Forecast by Regions (2021-2025)
12.3 North America Viral Vectors and Plasmid DNA Manufacturing Revenue Market Forecast (2021-2025)
12.4 Europe Viral Vectors and Plasmid DNA Manufacturing Revenue Market Forecast (2021-2025)
12.5 Asia-Pacific Viral Vectors and Plasmid DNA Manufacturing Revenue Market Forecast (2021-2025)
12.6 South America Viral Vectors and Plasmid DNA Manufacturing Revenue Market Forecast (2021-2025)
12.7 Middle East & Africa Viral Vectors and Plasmid DNA Manufacturing Revenue Market Forecast (2021-2025)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
14.3 Disclaimer
14.4 About US
Table 1. Global Viral Vectors and Plasmid DNA Manufacturing Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Viral Vectors and Plasmid DNA Manufacturing by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Viral Vectors and Plasmid DNA Manufacturing Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Global Market Viral Vectors and Plasmid DNA Manufacturing Revenue (Million USD) Comparison by Regions 2015-2025
Table 5. Global Viral Vectors and Plasmid DNA Manufacturing Market Size and Growth Estimation in Various Scenarios in 2020
Table 6. BioReliance Corporate Information, Location and Competitors
Table 7. BioReliance Viral Vectors and Plasmid DNA Manufacturing Major Business
Table 8. BioReliance Viral Vectors and Plasmid DNA Manufacturing Total Revenue (USD Million) (2017-2018)
Table 9. BioReliance SWOT Analysis
Table 10. BioReliance Viral Vectors and Plasmid DNA Manufacturing Product and Solutions
Table 11. BioReliance Viral Vectors and Plasmid DNA Manufacturing Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 12. Richter-Helm Corporate Information, Location and Competitors
Table 13. Richter-Helm Viral Vectors and Plasmid DNA Manufacturing Major Business
Table 14. Richter-Helm Viral Vectors and Plasmid DNA Manufacturing Total Revenue (USD Million) (2018-2019)
Table 15. Richter-Helm SWOT Analysis
Table 16. Richter-Helm Viral Vectors and Plasmid DNA Manufacturing Product and Solutions
Table 17. Richter-Helm Viral Vectors and Plasmid DNA Manufacturing Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 18. UniQure Corporate Information, Location and Competitors
Table 19. UniQure Viral Vectors and Plasmid DNA Manufacturing Major Business
Table 20. UniQure Viral Vectors and Plasmid DNA Manufacturing Total Revenue (USD Million) (2017-2018)
Table 21. UniQure SWOT Analysis
Table 22. UniQure Viral Vectors and Plasmid DNA Manufacturing Product and Solutions
Table 23. UniQure Viral Vectors and Plasmid DNA Manufacturing Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 24. Cobra Biologics Corporate Information, Location and Competitors
Table 25. Cobra Biologics Viral Vectors and Plasmid DNA Manufacturing Major Business
Table 26. Cobra Biologics Viral Vectors and Plasmid DNA Manufacturing Total Revenue (USD Million) (2017-2018)
Table 27. Cobra Biologics SWOT Analysis
Table 28. Cobra Biologics Viral Vectors and Plasmid DNA Manufacturing Product and Solutions
Table 29. Cobra Biologics Viral Vectors and Plasmid DNA Manufacturing Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 30. MassBiologics Corporate Information, Location and Competitors
Table 31. MassBiologics Viral Vectors and Plasmid DNA Manufacturing Major Business
Table 32. MassBiologics Viral Vectors and Plasmid DNA Manufacturing Total Revenue (USD Million) (2017-2018)
Table 33. MassBiologics SWOT Analysis
Table 34. MassBiologics Viral Vectors and Plasmid DNA Manufacturing Product and Solutions
Table 35. MassBiologics Viral Vectors and Plasmid DNA Manufacturing Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 36. Oxford BioMedica Corporate Information, Location and Competitors
Table 37. Oxford BioMedica Viral Vectors and Plasmid DNA Manufacturing Major Business
Table 38. Oxford BioMedica Viral Vectors and Plasmid DNA Manufacturing Total Revenue (USD Million) (2017-2018)
Table 39. Oxford BioMedica SWOT Analysis
Table 40. Oxford BioMedica Viral Vectors and Plasmid DNA Manufacturing Product and Solutions
Table 41. Oxford BioMedica Viral Vectors and Plasmid DNA Manufacturing Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 42. Lonza Corporate Information, Location and Competitors
Table 43. Lonza Viral Vectors and Plasmid DNA Manufacturing Major Business
Table 44. Lonza Viral Vectors and Plasmid DNA Manufacturing Total Revenue (USD Million) (2017-2018)
Table 45. Lonza SWOT Analysis
Table 46. Lonza Viral Vectors and Plasmid DNA Manufacturing Product and Solutions
Table 47. Lonza Viral Vectors and Plasmid DNA Manufacturing Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 48. MolMed Corporate Information, Location and Competitors
Table 49. MolMed Viral Vectors and Plasmid DNA Manufacturing Major Business
Table 50. MolMed Viral Vectors and Plasmid DNA Manufacturing Total Revenue (USD Million) (2017-2018)
Table 51. MolMed SWOT Analysis
Table 52. MolMed Viral Vectors and Plasmid DNA Manufacturing Product and Solutions
Table 53. MolMed Viral Vectors and Plasmid DNA Manufacturing Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 54. FinVector Corporate Information, Location and Competitors
Table 55. FinVector Viral Vectors and Plasmid DNA Manufacturing Major Business
Table 56. FinVector Viral Vectors and Plasmid DNA Manufacturing Total Revenue (USD Million) (2017-2018)
Table 57. FinVector SWOT Analysis
Table 58. FinVector Viral Vectors and Plasmid DNA Manufacturing Product and Solutions
Table 59. FinVector Viral Vectors and Plasmid DNA Manufacturing Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 60. FUJIFILM Diosynth Biotechnologies Corporate Information, Location and Competitors
Table 61. FUJIFILM Diosynth Biotechnologies Viral Vectors and Plasmid DNA Manufacturing Major Business
Table 62. FUJIFILM Diosynth Biotechnologies Viral Vectors and Plasmid DNA Manufacturing Total Revenue (USD Million) (2017-2018)
Table 63. FUJIFILM Diosynth Biotechnologies SWOT Analysis
Table 64. FUJIFILM Diosynth Biotechnologies Viral Vectors and Plasmid DNA Manufacturing Product and Solutions
Table 65. FUJIFILM Diosynth Biotechnologies Viral Vectors and Plasmid DNA Manufacturing Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 66. Brammer Bio Corporate Information, Location and Competitors
Table 67. Brammer Bio Viral Vectors and Plasmid DNA Manufacturing Major Business
Table 68. Brammer Bio Viral Vectors and Plasmid DNA Manufacturing Total Revenue (USD Million) (2017-2018)
Table 69. Brammer Bio SWOT Analysis
Table 70. Brammer Bio Viral Vectors and Plasmid DNA Manufacturing Product and Solutions
Table 71. Brammer Bio Viral Vectors and Plasmid DNA Manufacturing Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 72. Aldevron Corporate Information, Location and Competitors
Table 73. Aldevron Viral Vectors and Plasmid DNA Manufacturing Major Business
Table 74. Aldevron Viral Vectors and Plasmid DNA Manufacturing Total Revenue (USD Million) (2017-2018)
Table 75. Aldevron SWOT Analysis
Table 76. Aldevron Viral Vectors and Plasmid DNA Manufacturing Product and Solutions
Table 77. Aldevron Viral Vectors and Plasmid DNA Manufacturing Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 78. VGXI Corporate Information, Location and Competitors
Table 79. VGXI Viral Vectors and Plasmid DNA Manufacturing Major Business
Table 80. VGXI Viral Vectors and Plasmid DNA Manufacturing Total Revenue (USD Million) (2017-2018)
Table 81. VGXI SWOT Analysis
Table 82. VGXI Viral Vectors and Plasmid DNA Manufacturing Product and Solutions
Table 83. VGXI Viral Vectors and Plasmid DNA Manufacturing Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 84. Biovian Corporate Information, Location and Competitors
Table 85. Biovian Viral Vectors and Plasmid DNA Manufacturing Major Business
Table 86. Biovian Viral Vectors and Plasmid DNA Manufacturing Total Revenue (USD Million) (2017-2018)
Table 87. Biovian SWOT Analysis
Table 88. Biovian Viral Vectors and Plasmid DNA Manufacturing Product and Solutions
Table 89. Biovian Viral Vectors and Plasmid DNA Manufacturing Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 90. Eurogentec Corporate Information, Location and Competitors
Table 91. Eurogentec Viral Vectors and Plasmid DNA Manufacturing Major Business
Table 92. Eurogentec Viral Vectors and Plasmid DNA Manufacturing Total Revenue (USD Million) (2017-2018)
Table 93. Eurogentec SWOT Analysis
Table 94. Eurogentec Viral Vectors and Plasmid DNA Manufacturing Product and Solutions
Table 95. Eurogentec Viral Vectors and Plasmid DNA Manufacturing Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 96. PlasmidFactory Corporate Information, Location and Competitors
Table 97. PlasmidFactory Viral Vectors and Plasmid DNA Manufacturing Major Business
Table 98. PlasmidFactory Viral Vectors and Plasmid DNA Manufacturing Total Revenue (USD Million) (2017-2018)
Table 99. PlasmidFactory SWOT Analysis
Table 100. PlasmidFactory Viral Vectors and Plasmid DNA Manufacturing Product and Solutions
Table 101. PlasmidFactory Viral Vectors and Plasmid DNA Manufacturing Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 102. Cell and Gene Therapy Catapult Corporate Information, Location and Competitors
Table 103. Cell and Gene Therapy Catapult Viral Vectors and Plasmid DNA Manufacturing Major Business
Table 104. Cell and Gene Therapy Catapult Viral Vectors and Plasmid DNA Manufacturing Total Revenue (USD Million) (2017-2018)
Table 105. Cell and Gene Therapy Catapult SWOT Analysis
Table 106. Cell and Gene Therapy Catapult Viral Vectors and Plasmid DNA Manufacturing Product and Solutions
Table 107. Cell and Gene Therapy Catapult Viral Vectors and Plasmid DNA Manufacturing Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 108. Global Viral Vectors and Plasmid DNA Manufacturing Revenue (Million USD) by Players (2015-2020)
Table 109. Global Viral Vectors and Plasmid DNA Manufacturing Revenue Share by Players (2015-2020)
Table 110. Global Viral Vectors and Plasmid DNA Manufacturing Revenue (Million USD) by Regions (2015-2020)
Table 111. Global Viral Vectors and Plasmid DNA Manufacturing Revenue Market Share by Regions (2015-2020)
Table 112. North America Viral Vectors and Plasmid DNA Manufacturing Revenue by Countries (2015-2020)
Table 113. North America Viral Vectors and Plasmid DNA Manufacturing Revenue Market Share by Countries (2015-2020)
Table 114. Europe Viral Vectors and Plasmid DNA Manufacturing Revenue (Million USD) by Countries (2015-2020)
Table 115. Asia-Pacific Viral Vectors and Plasmid DNA Manufacturing Revenue (Million USD) by Countries (2015-2020)
Table 116. South America Viral Vectors and Plasmid DNA Manufacturing Revenue by Countries (2015-2020)
Table 117. South America Viral Vectors and Plasmid DNA Manufacturing Revenue Market Share by Countries (2015-2020)
Table 118. Middle East and Africa Viral Vectors and Plasmid DNA Manufacturing Revenue (Million USD) by Countries (2015-2020)
Table 119. Middle East and Africa Viral Vectors and Plasmid DNA Manufacturing Revenue Market Share by Countries (2015-2020)
Table 120. Global Viral Vectors and Plasmid DNA Manufacturing Revenue (Million USD) by Type (2015-2020)
Table 121. Global Viral Vectors and Plasmid DNA Manufacturing Revenue Share by Type (2015-2020)
Table 122. Global Viral Vectors and Plasmid DNA Manufacturing Revenue Forecast by Type (2021-2025)
Table 123. Global Viral Vectors and Plasmid DNA Manufacturing Revenue by Application (2015-2020)
Table 124. Global Viral Vectors and Plasmid DNA Manufacturing Revenue Share by Application (2015-2020)
Table 125. Global Viral Vectors and Plasmid DNA Manufacturing Revenue Forecast by Application (2021-2025)
Table 126. Global Viral Vectors and Plasmid DNA Manufacturing Revenue (Million USD) Forecast by Regions (2021-2025)
List of Figures
Figure 1. Viral Vectors and Plasmid DNA Manufacturing Picture
Figure 2. Global Viral Vectors and Plasmid DNA Manufacturing Revenue Market Share by Type in 2019
Figure 3. Plasmid DNA Picture
Figure 4. Viral Vectors Picture
Figure 5. Viral Vectors and Plasmid DNA Manufacturing Revenue Market Share by Application in 2019
Figure 6. Cancers Picture
Figure 7. Inherited Disorders Picture
Figure 8. Viral Infections Picture
Figure 9. Others Picture
Figure 10. Global Viral Vectors and Plasmid DNA Manufacturing Revenue (USD Million) and Growth Rate (2015-2025)
Figure 11. North America Viral Vectors and Plasmid DNA Manufacturing Revenue (Million USD) and Growth Rate (2015-2025)
Figure 12. Europe Viral Vectors and Plasmid DNA Manufacturing Revenue (Million USD) and Growth Rate (2015-2025)
Figure 13. Asia-Pacific Viral Vectors and Plasmid DNA Manufacturing Revenue (Million USD) and Growth Rate (2015-2025)
Figure 14. South America Viral Vectors and Plasmid DNA Manufacturing Revenue (Million USD) and Growth Rate (2015-2025)
Figure 15. Middle East and Africa Viral Vectors and Plasmid DNA Manufacturing Revenue (Million USD) and Growth Rate (2015-2025)
Figure 16. Global Viral Vectors and Plasmid DNA Manufacturing Revenue (Million USD) and Growth Rate (2015-2025)
Figure 17. Global Viral Vectors and Plasmid DNA Manufacturing Revenue Share by Players in 2019
Figure 18. Global Top 5 Players Viral Vectors and Plasmid DNA Manufacturing Revenue Market Share in 2019
Figure 19. Global Top 10 Players Viral Vectors and Plasmid DNA Manufacturing Revenue Market Share in 2019
Figure 20. Key Players Market Share Trend
Figure 21. Global Viral Vectors and Plasmid DNA Manufacturing Revenue (Million USD) and Growth Rate (%) (2015-2020)
Figure 22. Global Viral Vectors and Plasmid DNA Manufacturing Revenue Market Share by Regions (2015-2020)
Figure 23. Global Viral Vectors and Plasmid DNA Manufacturing Revenue Market Share by Regions in 2018
Figure 24. North America Viral Vectors and Plasmid DNA Manufacturing Revenue and Growth Rate (2015-2020)
Figure 25. Europe Viral Vectors and Plasmid DNA Manufacturing Revenue and Growth Rate (2015-2020)
Figure 26. Asia-Pacific Viral Vectors and Plasmid DNA Manufacturing Revenue and Growth Rate (2015-2020)
Figure 27. South America Viral Vectors and Plasmid DNA Manufacturing Revenue and Growth Rate (2015-2020)
Figure 28. Middle East and Africa Viral Vectors and Plasmid DNA Manufacturing Revenue and Growth Rate (2015-2020)
Figure 29. North America Viral Vectors and Plasmid DNA Manufacturing Revenue Market Share by Countries (2015-2020)
Figure 30. North America Viral Vectors and Plasmid DNA Manufacturing Revenue Market Share by Countries in 2019
Figure 31. USA Viral Vectors and Plasmid DNA Manufacturing Revenue and Growth Rate (2015-2020)
Figure 32. Canada Viral Vectors and Plasmid DNA Manufacturing Revenue and Growth Rate (2015-2020)
Figure 33. Mexico Viral Vectors and Plasmid DNA Manufacturing Revenue and Growth Rate (2015-2020)
Figure 34. Europe Viral Vectors and Plasmid DNA Manufacturing Revenue Market Share by Countries (2015-2020)
Figure 35. Europe Viral Vectors and Plasmid DNA Manufacturing Revenue Market Share by Countries in 2019
Figure 36. Germany Viral Vectors and Plasmid DNA Manufacturing Revenue and Growth Rate (2015-2020)
Figure 37. UK Viral Vectors and Plasmid DNA Manufacturing Revenue and Growth Rate (2015-2020)
Figure 38. France Viral Vectors and Plasmid DNA Manufacturing Revenue and Growth Rate (2015-2020)
Figure 39. Russia Viral Vectors and Plasmid DNA Manufacturing Revenue and Growth Rate (2015-2020)
Figure 40. Italy Viral Vectors and Plasmid DNA Manufacturing Revenue and Growth Rate (2015-2020)
Figure 41. Asia-Pacific Viral Vectors and Plasmid DNA Manufacturing Revenue Market Share by Countries (2015-2020)
Figure 42. Asia-Pacific Viral Vectors and Plasmid DNA Manufacturing Revenue Market Share by Countries in 2019
Figure 43. China Viral Vectors and Plasmid DNA Manufacturing Revenue and Growth Rate (2015-2020)
Figure 44. Japan Viral Vectors and Plasmid DNA Manufacturing Revenue and Growth Rate (2015-2020)
Figure 45. Korea Viral Vectors and Plasmid DNA Manufacturing Revenue and Growth Rate (2015-2020)
Figure 46. India Viral Vectors and Plasmid DNA Manufacturing Revenue and Growth Rate (2015-2020)
Figure 47. Southeast Asia Viral Vectors and Plasmid DNA Manufacturing Revenue and Growth Rate (2015-2020)
Figure 48. South America Viral Vectors and Plasmid DNA Manufacturing Revenue Market Share by Countries (2015-2020)
Figure 49. South America Viral Vectors and Plasmid DNA Manufacturing Revenue Market Share by Countries in 2019
Figure 50. Brazil Viral Vectors and Plasmid DNA Manufacturing Revenue and Growth Rate (2015-2020)
Figure 51. Argentina Viral Vectors and Plasmid DNA Manufacturing Revenue and Growth Rate (2015-2020)
Figure 52. Middle East and Africa Viral Vectors and Plasmid DNA Manufacturing Revenue Market Share by Countries (2015-2020)
Figure 53. Middle East and Africa Viral Vectors and Plasmid DNA Manufacturing Revenue Market Share by Countries in 2019
Figure 54. Saudi Arabia Viral Vectors and Plasmid DNA Manufacturing Revenue and Growth Rate (2015-2020)
Figure 55. UAE Viral Vectors and Plasmid DNA Manufacturing Revenue and Growth Rate (2015-2020)
Figure 56. Egypt Viral Vectors and Plasmid DNA Manufacturing Revenue and Growth Rate (2015-2020)
Figure 57. South Africa Viral Vectors and Plasmid DNA Manufacturing Revenue and Growth Rate (2015-2020)
Figure 58. Global Viral Vectors and Plasmid DNA Manufacturing Revenue Share by Type (2015-2020)
Figure 59. Global Viral Vectors and Plasmid DNA Manufacturing Revenue Share by Type in 2019
Figure 60. Global Viral Vectors and Plasmid DNA Manufacturing Market Share Forecast by Type (2021-2025)
Figure 61. Global Plasmid DNA Revenue Growth Rate (2015-2020)
Figure 62. Global Viral Vectors Revenue Growth Rate (2015-2020)
Figure 63. Global Viral Vectors and Plasmid DNA Manufacturing Revenue Share by Application (2015-2020)
Figure 64. Global Viral Vectors and Plasmid DNA Manufacturing Revenue Share by Application in 2019
Figure 65. Global Viral Vectors and Plasmid DNA Manufacturing Market Share Forecast by Application (2021-2025)
Figure 66. Global Cancers Revenue Growth Rate (2015-2020)
Figure 67. Global Inherited Disorders Revenue Growth Rate (2015-2020)
Figure 68. Global Viral Infections Revenue Growth Rate (2015-2020)
Figure 69. Global Others Revenue Growth Rate (2015-2020)
Figure 70. Global Viral Vectors and Plasmid DNA Manufacturing Revenue (Million USD) and Growth Rate Forecast (2021-2025)
Figure 71. Global Viral Vectors and Plasmid DNA Manufacturing Revenue (Million USD) Forecast by Regions (2021-2025)
Figure 72. Global Viral Vectors and Plasmid DNA Manufacturing Revenue Market Share Forecast by Regions (2021-2025)
Figure 73. North America Viral Vectors and Plasmid DNA Manufacturing Revenue Market Forecast (2021-2025)
Figure 74. Europe Viral Vectors and Plasmid DNA Manufacturing Revenue Market Forecast (2021-2025)
Figure 75. Asia-Pacific Viral Vectors and Plasmid DNA Manufacturing Revenue Market Forecast (2021-2025)
Figure 76. South America Viral Vectors and Plasmid DNA Manufacturing Revenue Market Forecast (2021-2025)
Figure 77. Middle East and Africa Viral Vectors and Plasmid DNA Manufacturing Revenue Market Forecast (2021-2025)
Figure 78. Sales Channel: Direct Channel vs Indirect Channel
ウイルスベクター・プラスミドDNAの世界市場 2020年：企業別、地域別、種類・用途別 Market Overview The Viral Vector and Plasmid DNA market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimi…- プラスミドの世界市場 2020年：企業別、地域別、種類・用途別 Market Overview The Plasmid market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulat…
- 抗ウイルス薬の世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global Anti-Viral Drugs market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Anti-Viral Drugs market repo…
- 細菌・ウイルス抗原の世界市場 2020年：企業別・地域別・種類別・用途別市場予測 Market Overview The Bacterial and Viral Antigens market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimi…
- タンパク質発現・精製技術の世界市場 2020年：企業別、地域別、種類・用途別 Market Overview The global Protein Expression and Purification Technology market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. Th…